Devin K. Schweppe

Devin K. Schweppe

Auto-generated profile, based on publicly available information

Devin K. Schweppe

University of Washington

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2017 in Nature
Verified
Journal Article
Open access
PDF file
EHEdward L. Huttlin
Edward L. Huttlin
RBRaphael J. Bruckner
Raphael J. Bruckner
JPJoao A. Paulo
Joao A. Paulo
JCJoe R. Cannon
Joe R. Cannon
LTLily Ting
Lily Ting
JHJ. Wade Harper
J. Wade Harper
Affinity purification–mass spectrometry elucidates protein interaction networks and co-complexes to build, to our knowledge, the largest experimentally derived human protein interaction network so far, termed BioPlex 2.0. The thousands of proteins within a cell function as modules and networks to coordinate their biological activities. Large-scale efforts are underway to build protein interaction maps that reveal cellular proteome architecture. Here, Wade Harper and colleagues use affinity purification mass spectrometry to elucidate protein interaction networks and co-complexes and build the largest experimentally derived human proteome interaction network to date, termed BioPlex 2.0. Containing over 29,000 novel co-associations and 1,300 protein communities representing diverse cellular activities, BioPlex 2.0 is more than double the size of their earlier interaction network BioPlex 1.0 and will be a valuable resource for exploring uncharacterized proteins and candidate disease-linked genes. The physiology of a cell can be viewed as the product of thousands of proteins acting in concert to shape the cellular response. Coordination is achieved in part through networks of protein–protein interactions that assemble functionally related proteins into complexes, organelles, and signal transduction pathways. Understanding the architecture of the human proteome has the potential to inform cellular, structural, and evolutionary mechanisms and is critical to elucidating how genome variation contributes to disease1,2,3. Here we present BioPlex 2.0 (Biophysical Interactions of ORFeome-derived complexes), which uses robust affinity purification–mass spectrometry methodology4 to elucidate protein interaction networks and co-complexes nucleated by more than 25% of protein-coding genes from the human genome, and constitutes, to our knowledge, the largest such network so far. With more than 56,000 candidate interactions, BioPlex 2.0 contains more than 29,000 previously unknown co-associations and provides functional insights into hundreds of poorly characterized proteins while enhancing network-based analyses of domain associations, subcellular localization, and co-complex formation. Unsupervised Markov clustering5 of interacting proteins identified more than 1,300 protein communities representing diverse cellular activities. Genes essential for cell fitness6,7 are enriched within 53 communities representing central cellular functions. Moreover, we identified 442 communities associated with more than 2,000 disease annotations, placing numerous candidate disease genes into a cellular framework. BioPlex 2.0 exceeds previous experimentally derived interaction networks in depth and breadth, and will be a valuable resource for exploring the biology of incompletely characterized proteins and for elucidating larger-scale patterns of proteome organization.

28 June 2011 in Science Signaling
Verified
Journal Article
Closed access
PDF file
AKArminja N. Kettenbach
Arminja N. Kettenbach
DSDevin K. Schweppe
Devin K. Schweppe
BFBrendan K. Faherty
Brendan K. Faherty
DPDov Pechenick
Dov Pechenick
APAlexandre A. Pletnev
Alexandre A. Pletnev
SGScott A. Gerber
Scott A. Gerber
Combining quantitative phosphoproteomics and selective kinase inhibition yields previously unknown substrates and functions of two families of mitotic kinases and refinement of their recognition motifs.

4 January 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
MKMiljan Kuljanin
Miljan Kuljanin
DMDylan C. Mitchell
Dylan C. Mitchell
DSDevin K. Schweppe
Devin K. Schweppe
AGAjami S. Gikandi
Ajami S. Gikandi
DNDavid P. Nusinow
David P. Nusinow
SGSteven P. Gygi
Steven P. Gygi

6 April 2020 in Journal of Proteome Research
Verified
Journal Article
Closed access
DSDevin K. Schweppe
Devin K. Schweppe
JEJimmy K. Eng
Jimmy K. Eng
QYQing Yu
Qing Yu
DBDerek Bailey
Derek Bailey
RRRamin Rad
Ramin Rad
SGSteven P. Gygi
Steven P. Gygi

23 January 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
DSDevin K. Schweppe
Devin K. Schweppe
SPSatendra Prasad
Satendra Prasad
MBMichael W. Belford
Michael W. Belford
JNJosé Navarrete-Perea
José Navarrete-Perea
DBDerek J. Bailey
Derek J. Bailey
SGSteven P. Gygi
Steven P. Gygi

27 January 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DSDevin K. Schweppe
Devin K. Schweppe
JCJuan D. Chavez
Juan D. Chavez
CLChi Fung Lee
Chi Fung Lee
ACArianne Caudal
Arianne Caudal
SKShane E. Kruse
Shane E. Kruse
JBJames E. Bruce
James E. Bruce
Significance: Mitochondria meet the majority of living cells’ demand for ATP and, as important regulators of redox homeostasis, metabolite levels, and calcium buffering, are a critical link between cell energetics and signaling. Disruption of these processes can induce adaptive or pathological signaling responses to stress and under severe stress promote cell death. Mitochondria have a complex proteome with conformations and interactions that are not well understood. Mitochondrial dysfunction is a direct cause of rare inherited diseases and is implicated in common metabolic diseases and age-related pathology. This study illuminates protein interactions and conformational features of nearly one-third of the mitochondrial proteome. Network information on this scale will enable groundbreaking insights into mitochondrial function, dysfunction, and potential therapeutic targets for mitochondrial-based pathology.